Matches in Nanopublications for { ?s ?p "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP743971.RA3CUtl8-cfmlIMXplWkBG4slfu78IF4eWwgfB8laph9I130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743971.RA3CUtl8-cfmlIMXplWkBG4slfu78IF4eWwgfB8laph9I130_provenance.
- NP885437.RAWwuDvjC1dhCJ0i0kxjGcl4aqMBvy6ihnkmdU0c34Nms130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885437.RAWwuDvjC1dhCJ0i0kxjGcl4aqMBvy6ihnkmdU0c34Nms130_provenance.
- assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP641341.RARDby2MohsGbkWYT8ASbCVADMnAXwqqSrp5MTYi4sd5g130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641341.RARDby2MohsGbkWYT8ASbCVADMnAXwqqSrp5MTYi4sd5g130_provenance.
- NP641346.RAZj76UxD-bhWJOzJwNFDWpblmvgt3Xys27KFwumZ44yQ130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641346.RAZj76UxD-bhWJOzJwNFDWpblmvgt3Xys27KFwumZ44yQ130_provenance.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.